Combination of a DPP IV inhibitor and an antiobesity or appetite regulating agent

Details for Australian Patent Application No. 2004290896 (hide)

Owner Novartis AG

Inventors Holmes, David Grenville

Agent Davies Collison Cave

Pub. Number AU-A-2004290896

PCT Pub. Number WO2005/049088

Priority 60/520,564 17.11.03 US

Filing date 16 November 2004

Wipo publication date 2 June 2005

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049088 Priority application(s): WO2005/049088

7 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290897-Use of dipeptidyl peptidase IV inhibitors

2004290893-Compositions comprising soy products and dioic acids